Literature DB >> 23078414

Importance of serrated polyps in colorectal carcinogenesis.

Jennifer J Liang1, Ian Bissett, Matthew Kalady, Ana Bennet, James M Church.   

Abstract

Colorectal cancer is an invasive neoplasm of the glandular epithelium of the colon and rectum that begins in a precursor lesion and expands to replace its lesion of origin. The majority of colorectal cancers arise from an adenoma, and the 'adenoma to carcinoma' pathway has been acknowledged for decades. More recently, another precursor lesion has been recognized: the serrated polyp. Serrated polyps are characterized by a sawtooth appearance of the crypt epithelium resulting from failure of apoptosis and a build-up of aging colonocytes. Although initially felt to be innocent of involvement in colorectal carcinogenesis, some types of serrated polyp are being increasingly recognized as precursor lesions, prone to develop into cancer, and likely to be a cause of 'missed' or interval cancers after colonoscopic screening. It is essential that gastrointestinal specialists appreciate the clinical significance of these lesions and what that means for colorectal cancer screening, and prevention. The purpose of this review is to highlight the importance serrated lesions of the colon and rectum, and to summarize current opinion on their natural history, diagnosis, surveillance and treatment.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23078414     DOI: 10.1111/j.1445-2197.2012.06269.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

1.  Screening colonoscopy intervals in familial colorectal cancer.

Authors:  Matthew F Kalady
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

Review 2.  Endoscopic and histologic characteristics of serrated lesions.

Authors:  Driffa Moussata; Gilles Boschetti; Marion Chauvenet; Karine Stroeymeyt; Stéphane Nancey; Françoise Berger; Thierry Lecomte; Bernard Flourié
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry.

Authors:  Lynn Butterly; Christina M Robinson; Joseph C Anderson; Julia E Weiss; Martha Goodrich; Tracy L Onega; Christopher I Amos; Michael L Beach
Journal:  Am J Gastroenterol       Date:  2014-01-07       Impact factor: 10.864

4.  Meat-derived carcinogens, genetic susceptibility and colorectal adenoma risk.

Authors:  Vikki Ho; Sarah Peacock; Thomas E Massey; Janet E Ashbury; Stephen J Vanner; Will D King
Journal:  Genes Nutr       Date:  2014-09-18       Impact factor: 5.523

5.  Up regulation of long non-coding RNAs BACE1 and down regulation of LINC-PINT are associated with CRC clinicopathological characteristics.

Authors:  Sara Bakhtiari-Nezhad; Leili Rejali; Mahrooyeh Hadizadeh; Mohammad Yaghob Taleghani; Hamid Asadzadeh Aghdaei; Chris Young; Binazir Khanabadi; Ehsan Nazemalhosseini-Mojarad; Maziar Ashrafian Bonab
Journal:  Mol Biol Rep       Date:  2022-09-10       Impact factor: 2.742

6.  A tumor microenvironment-specific gene expression signature predicts chemotherapy resistance in colorectal cancer patients.

Authors:  Xiaoqiang Zhu; Xianglong Tian; Linhua Ji; Xinyu Zhang; Yingying Cao; Chaoqin Shen; Ye Hu; Jason W H Wong; Jing-Yuan Fang; Jie Hong; Haoyan Chen
Journal:  NPJ Precis Oncol       Date:  2021-02-12

7.  Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Authors:  Laetitia Marisa; Aurélien de Reyniès; Alex Duval; Janick Selves; Marie Pierre Gaub; Laure Vescovo; Marie-Christine Etienne-Grimaldi; Renaud Schiappa; Dominique Guenot; Mira Ayadi; Sylvain Kirzin; Maurice Chazal; Jean-François Fléjou; Daniel Benchimol; Anne Berger; Arnaud Lagarde; Erwan Pencreach; Françoise Piard; Dominique Elias; Yann Parc; Sylviane Olschwang; Gérard Milano; Pierre Laurent-Puig; Valérie Boige
Journal:  PLoS Med       Date:  2013-05-21       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.